Header Logo

The "elusive DMOAD": Aggrecanase inhibition from laboratory to clinic.

The "elusive DMOAD": Aggrecanase inhibition from laboratory to clinic. Clin Exp Rheumatol. 2019 Sep-Oct; 37 Suppl 120(5):130-134.

View in: PubMed